Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 15/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6287156 | 1.00 | PTGDR2 (0.61) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL6287154 | 1.00 | PTGDR2 (0.61) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL6287163 | 0.93 | PTGDR2 (0.59) | PTGDR2MEN1KMT2A | |
| SCHEMBL5402868 | 0.91 | PTGDR2 (0.66) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5402860 | 0.91 | PTGDR2 (0.66) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5402858 | 0.91 | PTGDR2 (0.66) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL6244578 | 0.90 | PTGDR2 (0.53) | PTGDR2MEN1KMT2A | |
| SCHEMBL5397352 | 0.89 | PTGDR2 (0.76) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5397346 | 0.89 | PTGDR2 (0.76) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5397371 | 0.89 | PTGDR2 (0.76) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1556356-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS | Warner-Lambert Company LLC (US) | 2005-07-27 | — | — | EP | claimed |
| WO-2004035543-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-04-29 | — | — | WO | claimed |
| EP-1556356-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS | Warner-Lambert Company LLC (US) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004035543-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-04-29 | — | — | WO | disclosed |